MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Quaker BioVentures
*Portfolio Companies: Quaker BioVentures
Precision Therapeutics
Attachments
ptilabs
Parents
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology
*Industry: Pittsburgh, Pennsylvania
*Portfolio Companies: Bain
*Portfolio Companies: Quaker BioVentures
*Portfolio Companies: TVM
*WRI-Windber Research Institute: Academic & Industry Partners
Birchmere Ventures
Draper Triangle Ventures
Venture Capital: Series A
Children
Holly H. Gallion, MD
Investors included Adams Capital Management, Birchmere Investors, Hillman Co. and outside investors Quaker BioVentures in Philadelphia and Bain Capital
Last year, sales hit $23 million, almost triple the $8.5 million Precision posted in 2008 (2010)
Precision Therapeutics reels in $33M, hiring and opening a lab in the Chocolate Factory (2010)
Precision’s product, ChemoFx, helps to determine the most effective type of chemotherapy to treat individual patients’ tumors.
Sean McDonald, CEO
The latest round brings the total amount of capital raised by Precision to more than $100 million since it was founded (2010)